-
Ninth Circuit Confirms Bristol-Myers’ Rule Applies to Notice in FLSA Collective Actions
09 Jul 2025 02:58 GMT
… Supreme Court’s decision in Bristol-Myers Squibb Co. v. Superior Court … rendering nationwide notice improper?
In Bristol-Myers Squibb Co. v. Superior Court …
-
Digital Tech for Schizophrenia on Brink of a Breakthrough?
11 Jul 2025 12:45 GMT
… /trospium chloride (Cobenfy, Bristol Myers Squibb), many clinicians are calling for …
-
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
11 Jul 2025 12:11 GMT
… . ABBV
8.67%
14.77%
Bristol-Myers Squibb Co. BMY
-14.56% …
-
Amgen’s bemarituzumab shows promise in phase 3 gastric cancer study
11 Jul 2025 11:55 GMT
… evaluating bemarituzumab plus chemotherapy and Bristol Myers Squibb’s Opdivo (nivolumab) in …
-
Made-in-space meds get cash infusion
11 Jul 2025 09:37 GMT
… for the stars…Merck and Bristol Myers Squibb are experimenting with producing …
-
Cephalosporin Market to Reach $16.87 Billion by 2027, Bolstering Global Bacterial Infection Treatment
11 Jul 2025 07:58 GMT
… as -
Allergan Plc.,
Bristol-Myers Squibb Company,
F.Hoffmann-La Roche …
-
Top 10 Cancer Drugs Market Set to Skyrocket to Nearly $200 Billion by 2032 Amid Global Cancer Surge
11 Jul 2025 07:58 GMT
… Pharma Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann …
-
B-Cell Lymphoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, And Pipeline Analysis Lisocabtagene Maraleucel, Hoffmann-La Roche, Nektar Therapeutics, Miltenyi
11 Jul 2025 03:22 GMT
… treatment.
In May 2023, Bristol Myers Squibb reported positive topline results from … Lymphoma Emerging Drugs
Lisocabtagene maraleucel: Bristol Myers Squibb
Glofitamab: Hoffmann-La Roche …
-
Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight
11 Jul 2025 00:14 GMT
… , Merck, Genentech, GlaxoSmithKline, Bristol-Myers Squibb, among others.
Non-Small … Lilly and Company, Merck, Bristol-Myers Squibb, Roche, Shanghai Henlius Biotech … Biosciences, Inc., Aurora Biopharma, Bristol-Myers Squibb Company, CARsgenTherapeutics Co., Ltd …
-
Interstitial Lung Disease Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Roche, Atyr Pharma, Boehringer Ingelheim, Fibrogen, LTT Bio-Pharma, BMS
11 Jul 2025 03:22 GMT
… , FibroGen, LTT Bio-Pharma, Bristol-Myers Squibb, Prometheus Biosciences, HEC Pharm, Bayer …
About
© 1995-2025